Manama: The National Health Regulatory Authority (NHRA) has announced the withdrawal and suspension of registration of the pharmaceutical product “PROTON 40mg E.C TABLET – PROTON 20mg E.C TABLET”, produced by the Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO). The move is based on the warning issued by the Saudi Food and Drug Authority (SFDA) on March 12, 2021. The NHRA indicated said that it has withdrawn the medicine from the Kingdom, and suspended its registration because it does not match the original product. The NHRA recommended the health authorities to withdraw the product as soon as it is available to them, calling on the medicine users to contact their doctors to receive the alternative medication.
Trending
- UAE President, Turkish Foreign Minister discuss bilateral relations, regional developments
- Information Minister highlights the legacy of Dr. Mohammed Jaber Al Ansari
- Tourism Minister highlights Muharraq Nights’ role in promoting cultural identity
- Royal Court mourns the passing of Dr. Mohammed Al Ansari
- BIC offers festive thrills with Open Track Day and Track Experiences this weekend
- HH Shaikh Mohammed bin Salman bin Hamad Al Khalifa chairs a meeting reviewing developments in the Bahrain Mangroves initiative
- HM King condoles with family of the first Jordanian Ambassador to Bahrain
- HRH the Crown Prince and Prime Minister inaugurates the Electricity and Water Control Center
